Randomized Phase II Study of CABAZITAXEL versus METHOTREXATE in patients with recurrent or metastatic squamous cell carcinoma of the head and neck previously treated with platinum-based therapy
Phase of Trial: Phase II
Latest Information Update: 19 Jun 2017
At a glance
- Drugs Cabazitaxel (Primary) ; Methotrexate
- Indications Head and neck cancer
- Focus Therapeutic Use
- Acronyms RACATREX
- 02 Jun 2015 Primary endpoint (Progression-free survival rate) has not been met as per results presented at the 51st Annual Meeting of the American Society of Clinical Oncology. .
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 29 Sep 2012 New source identified and integrated (European Clinical Trials Database: EudraCT2011-001938-42).